Bachem sits near 30% against roughly 19% to 24% for Siegfried, Recipharm and Axplora. Sekhar credits its focus on peptides and oligonucleotides.
Recap by typeshit. Post by Sekhar on X.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Per the AP, the policy would give pharmacies cover to make peptides that FDA staff scientists say lack safety and efficacy data. CSPI is pushing back hard.
An explainer on pill-form peptide drugs, noting that only a small share of each dose actually gets absorbed by the body.
Loading…